Novartis NVA237 Phase III data showed rapid, sustained improvement in lung function and symptom relief over one year in COPD patients
17 May 2012
Results from pivotal Phase III GLOW2 study...


Amgen’s BiTE® Antibody Blinatumomab achieved high rate of complete response in adult patients with relapsed or refractory acute lymphoblastic leukemia
GlaxoSmithKline completes transaction to increase its ownership in Theravance
Roche will report new data on important progress for people with advanced cancers at ASCO 2012
Bristol-Myers Squibb Foundation announces $15 million expansion of Together on Diabetes® to China and India
Catalent announces winners of Global Academic Competition for Life Science Leaders of Tomorrow
Avalanche and Lonza announce global manufacturing collaboration for AAV vectors for gene therapy
Syrris Asia Heater – flow chemistry 1000x faster
B&W Tek announces a quantum leap in the evolution of miniature CCD spectrometer technology
Cisbio Bioassays adds three cellular kinase assays to its kinase screening platform
Patheon transformation continues with adjustments to its global platform
BASF acquires global leader in omega-3 fatty acids for the pharmaceutical industry
Customers celebrate the launch of Tecan Australia
Gerresheimer shows syringe systems at Korea Pack 2012


Cape Cod Inc. interviewed by European Pharmaceutical Review at Interphex 2012
Login to access exclusive content